Two groundbreaking studies shed light on combat’s lasting physical and psychological damage more than 50 years on.

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim ...

Although their diagnosis about what ails U.S. healthcare and their prescription for remedying it are almost entirely from ...

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

An expert discusses the current understanding of corticosteroids in managing pulmonary fibrosis and how it has evolved in ...

Vaccines are not mentioned in the order but there are references to overmedication of children and undue industry influence.